BCL2 and acute myeloid leukemia: AML with mutated NPM1 was the most common type within the “AML with recurrent genetic abnormalities” category, occurring in 24% of all AML cases and in 23.8% and 23% of BCL-2− and BCL-2+ AML cases, respectively.